407 Views
Penicillin MIC (µg/mL) | |||||
0 | 1 | 2 | 3 | 4 | |
≤ 0.125 | 26* | 12 | 8 | 17 | 43 |
0.25-0.5 | 4 | 2 | 1 | 1 | 5 |
1 | 1 | 0 | 0 | 3 | 1 |
2 | 4 | 0 | 0 | 2 | 5 |
≥4 | 1 | 2 | 1 | 2 | 4 |
Sheldon L. Kaplan, MD
Professor
Baylor College of Medicine
Houston, Texas
Disclosure: Allergan (Research Grant or Support)Pfizer (Grant/Research Support)
William J. Barson, MD
Professor
Ohio State University College of Medicine and Public Health and Nationwide Children's Hospital
Columbus, Ohio
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Philana L. Lin, MD, MSc
Associate Professor
UPMC Children's Hospital of PIttsburgh
Pittsburgh, Pennsylvania
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jose R. Romero, MD
Professor
University of Arkansas for Medical Sciences and Arkansas Children's Hospital
Little Rock, Arkansas
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John S. Bradley, MD
Professor
University of California San Diego/Rady Children's Hospital
San Diego, California
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tina Q. Tan, MD
Professor
Feinberg School of Medicine, Northwestern University
Chicago, Illinois
Disclosure: Pfizer (Grant/Research Support, Other Financial or Material Support, Chair, DMSB for PCV20 vaccine)
Pia S. Pannaraj, MD, MPH
Associate Professor
Children's Hospital Los Angeles
Los Angeles, California
Disclosure: AstraZeneca (Grant/Research Support)Pfizer (Grant/Research Support)Sanofi Pasteur (Advisor or Review Panel member)
Larry Givner, MD
Professor of Pediatrics
Wake Forest School of Medicine
Winston Salem, North Carolina
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kristina G. Hulten, PhD
Associate Professor
Baylor College of Medicine
Houston, Texas
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.